HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasufumi Masaki Selected Research

Agraphia (Dysgraphia)

5/2022A Case Report on Dysgraphia in a Patient Receiving Blinatumomab: Complex Characters Are Easy to Find in a Handwriting Test.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasufumi Masaki Research Topics

Disease

15Immunoglobulin G4-Related Disease
12/2021 - 12/2009
14Lymphoma (Lymphomas)
03/2022 - 06/2003
13Neoplasms (Cancer)
05/2022 - 05/2002
11Fever (Fevers)
05/2022 - 06/2009
11Multi-centric Castleman's Disease
05/2022 - 04/2010
10Thrombocytopenia (Thrombopenia)
05/2022 - 10/2010
9Edema (Dropsy)
05/2022 - 01/2013
7Fibrosis (Cirrhosis)
05/2022 - 11/2010
7Castleman Disease (Castleman's Disease)
03/2022 - 12/2009
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2021 - 08/2003
7Multiple Myeloma
05/2018 - 08/2009
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2020 - 07/2008
5Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2004 - 05/2002
4Primary Myelofibrosis (Myelosclerosis)
08/2021 - 12/2017
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2021 - 08/2003
3Renal Insufficiency (Renal Failure)
10/2019 - 01/2018
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2017 - 04/2004
3Disease Progression
07/2014 - 09/2010
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2012 - 08/2009
3Pancreatitis
01/2011 - 12/2009
3Rheumatoid Arthritis
10/2007 - 05/2002
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2022 - 04/2012
2Inflammation (Inflammations)
01/2021 - 01/2013
2Anemia
01/2019 - 12/2017
2Ascites
05/2018 - 01/2013
2Splenomegaly
12/2017 - 02/2014
2T-Cell Lymphoma (Lymphoma, T Cell)
12/2017 - 02/2006
2Body Weight (Weight, Body)
09/2017 - 01/2012
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 05/2011
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2014 - 01/2010
2Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2011 - 12/2009
2Sarcoidosis (Schaumann Disease)
01/2011 - 12/2009
2Sepsis (Septicemia)
07/2010 - 08/2009
2Lymphadenopathy
04/2010 - 12/2009
2Leukemia
07/2009 - 06/2003
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2008 - 03/2007
2Interstitial Lung Diseases (Interstitial Lung Disease)
10/2007 - 02/2003
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2003 - 08/2002
1Extranodal NK-T-Cell Lymphoma
10/2022
1Brain Diseases (Brain Disorder)
05/2022
1Drug-Related Side Effects and Adverse Reactions
05/2022
1Bites and Stings (Sting)
05/2022
1Philadelphia Chromosome
05/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2022
1cell-associated neurotoxicity
05/2022
1Agraphia (Dysgraphia)
05/2022
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
12/2021

Drug/Important Bio-Agent (IBA)

16Immunoglobulin G (IgG)IBA
12/2021 - 01/2006
11Rituximab (Mabthera)FDA Link
02/2021 - 01/2008
9Reticulin (Reticular Fiber)IBA
05/2022 - 01/2013
8Interleukin-6 (Interleukin 6)IBA
03/2022 - 04/2010
7Bortezomib (Velcade)FDA Link
05/2018 - 08/2009
7Dexamethasone (Maxidex)FDA LinkGeneric
05/2018 - 08/2009
6Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2002
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 10/2010
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 01/2013
5Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 01/2013
5Prednisolone (Predate)FDA LinkGeneric
01/2020 - 09/2010
5GlucocorticoidsIBA
05/2018 - 12/2009
4C-Reactive ProteinIBA
07/2022 - 01/2013
4CytokinesIBA
01/2021 - 05/2012
4DNA (Deoxyribonucleic Acid)IBA
01/2021 - 02/2006
4SteroidsIBA
05/2020 - 01/2013
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2018 - 01/2006
3AnthracyclinesIBA
10/2022 - 04/2012
3Immunoglobulins (Immunoglobulin)IBA
12/2021 - 07/2009
3Prednisone (Sone)FDA LinkGeneric
01/2021 - 01/2017
3RNA (Ribonucleic Acid)IBA
05/2020 - 02/2006
3Methotrexate (Mexate)FDA LinkGeneric
01/2020 - 05/2002
3AntigensIBA
01/2018 - 03/2007
3Etoposide (VP 16)FDA LinkGeneric
12/2017 - 02/2005
2AntibodiesIBA
05/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
12/2021 - 12/2017
2Immunoglobulin Fab FragmentsIBA
01/2018 - 10/2010
2Anaplastic Lymphoma KinaseIBA
12/2017 - 04/2004
2tocilizumab (atlizumab)FDA Link
06/2016 - 01/2013
2LeptinIBA
02/2014 - 01/2012
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
04/2012 - 02/2003
2Cytarabine (Cytosar-U)FDA LinkGeneric
04/2012 - 08/2009
2ParaffinIBA
02/2006 - 08/2003
1CholesterolIBA
07/2022
1AlbuminsIBA
07/2022
1blinatumomabIBA
05/2022
1Chimeric Antigen ReceptorsIBA
05/2022
1Busulfan (Busulfex)FDA Link
03/2022
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
03/2022
1Antineoplastic Agents (Antineoplastics)IBA
03/2022
1aziridine (ethyleneimine)IBA
03/2022
1Alkylating AgentsIBA
03/2022
1ClusterinIBA
12/2021
1Blood Proteins (Serum Proteins)IBA
12/2021
1SilverIBA
12/2021
1Leucine (L-Leucine)FDA Link
12/2021
1fibrin fragment D (D-dimer)IBA
08/2021

Therapy/Procedure

24Therapeutics
10/2022 - 02/2003
18Drug Therapy (Chemotherapy)
05/2022 - 05/2002
2Hematopoietic Stem Cell Transplantation
03/2022 - 09/2005
2Remission Induction
04/2012 - 05/2011
2Oral Administration
08/2009 - 02/2005
1Radioimmunotherapy
02/2021